Strumento inattivo

Azioni Immunosyn Corp

Azioni

Prezzo di chiusura Other OTC Altri mercati azionari
- ^USD	-

IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	16/07/08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	17/05/08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	31/03/08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	26/02/08
Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	01/02/08

Dirigenti	Titolo	Età	Da
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/10/07
Douglas A. McClain DFI	Director of Finance/CFO	49	-

Amministratori	Titolo	Età	Da
Douglas A. McClain DFI	Director of Finance/CFO	49	-
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/10/07

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,66%	86,13 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 Mrd
BIOGEN INC.	-19,27%	30,42 Mrd
UCB	+57,86%	25,23 Mrd
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,35 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 Mrd
INCYTE CORPORATION	-17,69%	11,6 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 Mrd